Sarissa Capital Management’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
Other funds holding VOR
Sarissa Capital Management's VOR Position: Q3 2026 in Review
Sarissa Capital Management held its Vor Biopharma (VOR) position steady in Q3 2026 at 25,399 shares worth $485K. The position accounts for 0.32% of the portfolio, ranked #9.
Sarissa Capital Management first reported a position in VOR in Q1 2021 and has held it in 23 quarters since. The position peaked at $30.5M in Q1 2021. 156 funds tracked by Wall St. Rank hold VOR as of Q3 2026.
- Sarissa Capital Management held 25,399 shares of Vor Biopharma worth $485K as of Q3 2026.
- Sarissa Capital Management left its Vor Biopharma share count unchanged in Q3 2026.
- Vor Biopharma made up 0.32% of Sarissa Capital Management's portfolio in Q3 2026, its #9 holding.
- Sarissa Capital Management first reported a position in Vor Biopharma in Q1 2021 and has held it in 23 quarters since.
- Sarissa Capital Management's Vor Biopharma position peaked at $30.5M in Q1 2021.
- 156 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.
Based on Sarissa Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.